MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
1.110
+0.030
+2.78%
After Hours: 1.080 -0.03 -2.70% 16:42 06/25 EDT
OPEN
1.050
PREV CLOSE
1.080
HIGH
1.167
LOW
1.012
VOLUME
22.54K
TURNOVER
--
52 WEEK HIGH
2.390
52 WEEK LOW
0.6765
MARKET CAP
9.06M
P/E (TTM)
-2.2240
1D
5D
1M
3M
1Y
5Y
1D
Immuron Completes Buy-Back of Unmarketable Parcels to Streamline Share Register
TipRanks · 2d ago
Weekly Report: what happened at IMRN last week (0615-0619)?
Weekly Report · 3d ago
Weekly Report: what happened at IMRN last week (0608-0612)?
Weekly Report · 06/15 10:14
Weekly Report: what happened at IMRN last week (0601-0605)?
Weekly Report · 06/08 10:10
Weekly Report: what happened at IMRN last week (0525-0529)?
Weekly Report · 06/01 10:14
Immuron says unaware of undisclosed information behind recent trading move after ASX query
PUBT · 05/28 12:02
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 05/27 21:05
Weekly Report: what happened at IMRN last week (0518-0522)?
Weekly Report · 05/25 10:17
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.